Next Article in Journal / Special Issue
Bioadhesive Properties of Gantrez Nanoparticles
Previous Article in Journal / Special Issue
AFM study of a New Carrier Based on PLA and Salen Copolymers for Gene Therapy
Molecules 2005, 10(1), 114-125; doi:10.3390/10010114

Covalent Polymer-Drug Conjugates

1,* , 1, 1 and 2
1 Institute of Polymer Science and Technology (CSIC), Spain 2 Institute of Industrial Fermentations (CSIC), Spain
* Author to whom correspondence should be addressed.
Received: 13 April 2004 / Accepted: 23 June 2004 / Published: 31 January 2005
(This article belongs to the Special Issue Macromolecules Applied to Pharmaceutical Chemistry)
View Full-Text   |   Download PDF [253 KB, uploaded 18 June 2014]   |  


In this work, polymer-drugs conjugates used as drug delivery systems (DDS) are revised attending to their chemical conjugation. Namely, the classification of this type of DDS is based on the conjugation sites of the reactive groups (i.e., via end groups or pendant polymer groups). Advantages and limitations of these types of DDS are discussed through representative examples of polymer-drugs and polymer-proteins conjugates recently developed.
Keywords: drug delivery system; DDS; polymer-drug; polymer-protein; conjugates drug delivery system; DDS; polymer-drug; polymer-protein; conjugates
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Elvira, C.; Gallardo, A.; Roman, J.; Cifuentes, A. Covalent Polymer-Drug Conjugates. Molecules 2005, 10, 114-125.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert